knowledge -WSS

knowledge

author：comprehensive 2025-10-02 11:04:47 - browse：7333

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Massive project maps cells in human brain in unprecedented detail

WSS

Nick Jonas talks about managing diabetes along with his career

Female surgeons have lower rates of long

RaDonda Vaught case: a double standard for nurses, physicians

Wellcome Trust names Røttingen as its new CEO

Humana CEO Bruce Broussard to step down in 2024

New case study details death in closely watched Alzhiemer's trial

knowledge

knowledge

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Peter Marks talks Operation Warp Speed for Rare Diseases

Activists slam private health insurers over coverage restrictions

Connecting traumatic brain injury and domestic violence

What does generative AI mean for health care? We asked experts

Female surgeons have lower rates of long

Peter Hotez and the public health issue of online harassment

Nick Jonas talks about managing diabetes along with his career

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Inside the fall of star MIT scientist David Sabatini

leisure time

Medicare to cover more brain scans related to Alzheimer’s drugs

What the Wegovy shortage looks like for doctors — and for patients

STAT Readout: Today's biotech news includes Sana and Amylyx

A new study asks: Are we harming blood donors by taking blood?

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Readout LOUD podcast: Merger Mondays, Ozempic panic

Wikipedia

leisure time

focus

leisure time